Genesis Research and Clinical Outcomes Solutions announce innovative partnership
July 21, 2022 | COA, Clinical Outcomes Assessment, HEOR, HTA, Health Economics Outcomes Research, Market Access, PRO, Patient reported outcome, PayerResearch, RWE, health technology assessment, payer research, real world data, real-world evidence
International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS).
International Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) organization Genesis Research is delighted to announce an exciting new partnership with Clinical Outcomes Assessment (COA) specialist Clinical Outcomes Solutions (COS).
As the regulatory landscape with respect to RWE continues to evolve, this innovative partnership brings together COS’s Clinical Outcomes Assessment scientific and clinical trial expertise and the evidence-based expertise of Genesis Research – keeping both companies firmly at the forefront of this ever-changing landscape to the wider benefit of clients, payers, and regulators.
Established in 2013, COS is a global leader in delivering innovative science to capture and communicate the patient voice, in order to provide actionable evidence in clinical drug development through qualitative and quantitative research, with a specific focus on Clinical Outcomes Assessments.
Genesis Research is an international RWE and HEOR organization that delivers scientifically rigorous, tech-enabled solutions to pharmaceutical, biotech, and medical device clients across the product lifecycle.
Stacie Hudgens, Chief Executive Officer at Clinical Outcomes Solutions, said:
“Clinical Outcomes Solutions was founded in 2013 with a specific focus on bringing innovative scientific solutions to patient-centered research. Our longstanding relationship with Genesis Research transitioning to a scientific partnership with the Oncology Outcomes network of partners continues to expand that focus.
“Evidence generation of patient-centered outcomes begins with prospective and clinical studies and expands through real-world treatment experience and symptoms management. This partnership, along with the additional Oncology Outcomes partners, provides Life Sciences Companies (LSCs) with a comprehensive body of evidence to support new anti-cancer therapy clinical development programs.”
Chris Pashos, Member, Board of Directors, Genesis Research, said:
“Regulatory bodies around the world have made Real-World Evidence and Clinical Outcomes Assessments central to their consideration of new therapies developed by Life Sciences Companies. This partnership offers LSCs the combined capabilities of leaders in these areas. Together the partnership can ensure that LSCs develop and execute timely strategies that will meet the evidentiary requirements of regulators.”
Susan Oliveria, Chief Scientific Officer, Genesis Research, said:
“RWE and COA are now recognized as central to the development and commercialization of new therapies. The partnership offers LSCs the ability to successfully plan and execute an integrated evidence generation plan that will be patient-centric and meet the needs of regulators, payers, medical professionals, and the patient community.”
Tara Symonds, Chief Science Officer at Clinical Outcomes Solutions, said:
“Real-world studies to capture patient-centred effectiveness data require careful design, implementation and analysis given the often-uncontrolled nature of the study design. Bringing together our organizations – and with this our respective skillsets and proven expertise – will provide an industry-leading offering for Life Sciences Companies to leverage, especially given the increasing interest and request for such data by both regulators and payers.”
Further information:
About Clinical Outcomes Solutions
Clinical Outcomes Solutions, founded in 2013, is a solution-focused team with global experience committed to bringing together the right team of experts to approach medical research questions. The expert team provides clients with the most effective clinical outcome solution to help make the right patient care value decisions. COS has expertise in qualitative and quantitative research that will result in actionable evidence to support clinical and regulatory strategies for both the US and European markets. For more information, please visit www.clinoutsolutions.com.
About Genesis Research
Genesis Research is an international Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) research organization that supports the life sciences industry. As a leader in evidence strategy, generation and communication, the company also supports pharmaceutical and biotech clients with tech-enabled, dedicated partnerships delivered via a unique engagement model that enables life sciences companies to address complex needs with unmatched timeliness and quality. For more information, visit www.genesisrg.com.
Contact:
Genesis Research: Richard Chumbley rchumbley@genesisrg.com
Clinical Outcomes Solutions: Clare Grove clare@makeitdrive.co.uk
This content was provided by Genesis Research Group
Company Details
Latest Content from Genesis Research Group
Tim Wright Updates ISPOR Europe MFN Pricing Presentation in New Interview
At ISPOR Europe in Glasgow, there were literal queues around the block for Tim Wright's HEOR Theater presentation 'MFN Pricing: More Fun to Navigate – A European Roadmap to Success,' with potentially...
Genesis Research Group contributes strong scientific program to ISPOR Europe and warmly invites visitors to booth 212
Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific program that includes an HEOR Theater session, contributions to 10...
ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs
On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...
Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies
HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.
Genesis Research Group Appoints Tim Wright as Executive Vice President, Access and Pricing
Genesis Research Group, a leading provider of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the appointment of Tim Wright as Executive Vice...
Navigating US market access analytics: A conversation with Ki Park
In the rapidly evolving landscape of healthcare and pharmaceutical market access, data analytics has become a critical component for making informed decisions. We sat down with Ki Park, our Vice...
Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.
In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...
Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program
Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...
Genesis Research Group survey discovers how payers are responding to Maximum Fair Prices (MFPs) under the Inflation Reduction Act
To better understand how MFPs might impact payer utilization management strategies, rebate negotiations, and business approaches, Genesis Research Group employed their RPR stakeholder engagement platform and vetted stakeholder network to...
Genesis Research Group ISPOR Europe presentation ‘Planning with Insights: Even the Best Economic Models Need Validation’ features in scientific publication
We are pleased to share that The Evidence Base have carried out a 'deep dive' into a Genesis Research Group presentation on economic modeling in healthcare and harnessing stakeholder insights...